Probing the limits of Q-tag bioconjugation of antibodies.

Autor: Marculescu, Cristina, Lakshminarayanan, Abirami, Gault, Joseph, Knight, James C., Folkes, Lisa K., Spink, Thomas, Robinson, Carol V., Vallis, Katherine, Davis, Benjamin G., Cornelissen, Bart
Zdroj: Chemical Communications; 9/28/2019, Vol. 55 Issue 76, p11342-11345, 4p
Abstrakt: Site-selective labelling of antibodies (Abs) can circumvent problems from heterogeneity of conventional conjugation. Here, we evaluate the industrially-applied chemoenzymatic 'Q-tag' strategy based on transglutaminase-mediated (TGase) amide-bond formation in the generation of 89Zr-radiolabelled antibody conjugates. We show that, despite previously suggested high regioselectivity of TGases, in the anti-Her2 Ab Herceptin™ more precise native MS indicates only 70–80% functionalization at the target site (Q298H), in competition with modification at other sites, such as Q3H critically close to the CDR1 region. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index